Patents by Inventor Iris Alroy

Iris Alroy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20230212131
    Abstract: The present invention relates to novel Collagen 1 translation inhibitors, composition and methods of preparation thereof, and uses thereof for treating Fibrosis including lung, liver, kidney, cardiac and dermal fibrosis, IPF, wound healing, scarring and Gingival fibromatosis, Systemic Sclerosis, and alcoholic and non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: June 9, 2021
    Publication date: July 6, 2023
    Applicant: Anima Biotech Inc.
    Inventors: David William SHEPPARD, Jason Paul TIERNEY, Aviad MANDABI, Wolfgang SCHMIDT, Stefano LEVANTO, Julie Nicole HAMBLIN, Richard James BULL, Iris ALROY, Wissam MANSOUR, Moty KLEPFISH, Yaode WANG, Haitang LI
  • COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20230150980
    Abstract: The present invention relates to novel Collagen I translation inhibitors, composition and methods of preparation thereof, and uses thereof for treating Fibrosis including lung, liver, kidney, cardiac and dermal fibrosis, IPF, wound healing, scarring and Gingival fibromatosis, Systemic Sclerosis, and alcoholic and non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: April 21, 2021
    Publication date: May 18, 2023
    Applicant: Anima Biotech Inc.
    Inventors: David William SHEPPARD, Jason Paul TIERNEY, Aviad MANDABI, Wolfgang SCHMIDT, Stefano LEVANTO, Julie Nicole HAMBLIN, Richard James BULL, Iris ALROY, Wissam MANSOUR, Moty KLEPFISH, Yaode WANG, Haitang Ll, Stephen David PENROSE
  • COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20230116201
    Abstract: The present invention relates to novel Collagen 1 translation inhibitors, composition and methods of preparation thereof, and uses thereof for treating Fibrosis including lung, liver, kidney, cardiac and dermal fibrosis, IPF, wound healing, scarring and Gingival fibromatosis, Systemic Sclerosis, and alcoholic and non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: January 28, 2021
    Publication date: April 13, 2023
    Applicant: Anima Biotech Inc.
    Inventors: David William SHEPPARD, Jason Paul TIERNEY, Wolfgang SCHMIDT, William Rameshchandra ESMIEU, Julie Nicole HAMBLIN, Richard James BULL, Iris ALROY, Wissam MANSOUR, Moty KLEPFISH, Aviad MANDABI
  • C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER
    Publication number: 20220370431
    Abstract: The present invention relates to novel c-MYC mRNA translation modulators, composition and methods of preparation thereof, and uses thereof in the treatment of cancer.
    Type: Application
    Filed: July 3, 2022
    Publication date: November 24, 2022
    Applicant: Anima Biotech Inc.
    Inventors: David William SHEPPARD, Jason Paul TIERNEY, Aviad MANDABI, Iris ALROY, Rina WASSERMANN, Yaode WANG, Haitang LI, Yoni SHEINBERGER
  • Functional tRNA-aptamer molecules
    Patent number: 11085045
    Abstract: The present invention provides functional aptamer-comprising tRNA molecules, useful in the study of tRNA and ribosomal activity.
    Type: Grant
    Filed: November 16, 2016
    Date of Patent: August 10, 2021
    Assignees: Anima Biotech Inc., Thomas Jefferson University
    Inventors: Iris Alroy, Ya-Ming Hou, Howard Gamper
  • FUNCTIONAL TRANSFER tRNA-APTAMER MOLECULES
    Publication number: 20180320183
    Abstract: The present invention provides functional aptamer-comprising tRNA molecules, useful in the study of tRNA and ribosomal activity.
    Type: Application
    Filed: November 16, 2016
    Publication date: November 8, 2018
    Inventors: Iris ALROY, Ya-Ming HOU, Howard GAMPER
  • Sulfonamide derivatives with therapeutic indications
    Patent number: 9422235
    Abstract: The invention provides sulfonamide compounds of formula (I) as defined herein, pharmaceutical compositions containing the same and methods of treatment using such compounds and pharmaceutical compositions. These compounds have a common wide range of beneficial therapeutic indications, in particular as analgesic and anti-inflammatory agents.
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: August 23, 2016
    Assignee: Pharmos Corporation
    Inventors: Avihai Yacovan, Iris Alroy, Alexander Aizikovich, Sima Mirilashvili, Flavio Grynszpan
  • SULFONAMIDE DERIVATIVES WITH THERAPEUTIC INDICATIONS
    Publication number: 20100056528
    Abstract: The invention provides sulfonamide compounds of formula (I) as defined herein, pharmaceutical compositions containing the same and methods of treatment using such compounds and pharmaceutical compositions. These compounds have a common wide range of beneficial therapeutic indications, in particular as analgesic and anti-inflammatory agents.
    Type: Application
    Filed: December 19, 2007
    Publication date: March 4, 2010
    Inventors: Avihai Yacovan, Iris Alroy, Alexander Aizikovich, Sima Mirilashvili, Flavio Gryszpan
  • Ubiquitin ligase inhibitors and methods related thereto
    Patent number: 7659277
    Abstract: The application discloses compounds that inhibit ubiquitin ligase activity. The application further discloses antiviral compounds, anticancer compounds, and compounds useful for the treatment of neurological disorders.
    Type: Grant
    Filed: January 11, 2006
    Date of Patent: February 9, 2010
    Assignee: Proteologies, Ltd.
    Inventors: Iris Alroy, Shmuel Tuvia, Yuval Reiss, Ofra Levi-Hacham
  • Treatment Of Lower Urinary Tract Dysfunction With CB2-Receptor-Selective Agonists
    Publication number: 20090312414
    Abstract: A method is disclosed utilizing a cannabinoid receptor type 2-receptor-selective agonist for treating or preventing lower urinary tract dysfunction, including overactive bladder, lower urinary tract symptoms and detrusor overactivity.
    Type: Application
    Filed: May 14, 2009
    Publication date: December 17, 2009
    Applicant: The Procter & Gamble Company
    Inventors: Jan Susan Rosenbaum, Karl-Erik Andersson, Iris Alroy
  • POSH nucleic acids, polypeptides and related methods
    Patent number: 7429643
    Abstract: The application discloses novel polypeptides and nucleic acids involved in a variety of biological processes, including viral reproduction. Related methods and compositions are also described.
    Type: Grant
    Filed: January 6, 2005
    Date of Patent: September 30, 2008
    Assignee: Proteologics, Inc.
    Inventors: Iris Alroy, Tsvika Greener, Shmuel Tuvia, Danny Ben-Avraham
  • Posh nucleic acids, polypeptides and related methods
    Publication number: 20080187538
    Abstract: The application discloses novel polypeptides and nucleic acids involved in a variety of biological processes, including viral reproduction. Related methods and compositions are also described.
    Type: Application
    Filed: July 30, 2007
    Publication date: August 7, 2008
    Applicant: Proteologics, Inc.
    Inventors: Iris Alroy, Tsvika Greener, Shmuel Tuvia, Danny Ben-Avraham
  • Posh Associated Kinases And Related Methods
    Publication number: 20070275368
    Abstract: The application provides novel complexes of POSH polypeptides and POSH asoociated kinases. The application also provides methods and compositions for treating a POSH-associated diseases such as viral disorders and cancer.
    Type: Application
    Filed: February 5, 2004
    Publication date: November 29, 2007
    Applicants: PROTEOLOGICS, LTD., PROTEOLOGICS. INC.
    Inventors: Iris Alroy, Yuval Reiss, Daniel Taglicht, Shmuel Tuvia, Liora Yaar
  • Posh nucleic acids, polypeptides and related methods
    Patent number: 7268227
    Abstract: The application discloses novel polypeptides and nucleic acids involved in a variety of biological processes, including viral reproduction. Related methods and compositions are also described.
    Type: Grant
    Filed: January 7, 2005
    Date of Patent: September 11, 2007
    Assignee: Proteologics, Inc.
    Inventors: Iris Alroy, Tsvika Greener, Shmuel Tuvia, Danny Ben-Avraham
  • POSH nucleic acids, polypeptides and related methods
    Patent number: 7250250
    Abstract: The application discloses novel polypeptides and nucleic acids involved in a variety of biological processes, including viral reproduction. Related methods and compositions are also described.
    Type: Grant
    Filed: November 12, 2002
    Date of Patent: July 31, 2007
    Assignee: Proteologics, Inc.
    Inventors: Iris Alroy, Tsvika Greener, Shmuel Tuvia, Danny Ben-Avraham
  • Posh polypeptides, complexes and related methods
    Publication number: 20070122807
    Abstract: The application provides novel complexes of POSH polypeptides and POSH-associated proteins. The application also provides methods and compositions for treating POSH-associated diseases such as neurological disorders.
    Type: Application
    Filed: April 5, 2004
    Publication date: May 31, 2007
    Applicant: Proteologics, Inc.
    Inventors: Iris Alroy, Yuval Reiss, Daniel Taglicht, Liora Yaar
  • Cbl-b polypeptides, complexes and related methods
    Publication number: 20070054355
    Abstract: The application provides novel complexes of Cbl-b polypeptides and Cbl-b-associated proteins. The application also provides methods and compositions for treating Cbl-b-associated diseases such as viral disorders.
    Type: Application
    Filed: March 5, 2004
    Publication date: March 8, 2007
    Inventors: Yuval Reiss, Daniel Taglicht, Iris Alroy, Shmuel Tuvia, Haim Barr
  • Ubiquitin ligase inhibitors and methods related thereto
    Publication number: 20070015768
    Abstract: The application discloses compounds that inhibit ubiquitin ligase activity. The application further discloses antiviral compounds, anticancer compounds, and compounds useful for the treatment of neurological disorders.
    Type: Application
    Filed: January 11, 2006
    Publication date: January 18, 2007
    Inventors: Iris Alroy, Shmuel Tuvia, Yuval Reiss, Ofra Levi-Hacham
  • Posh interacting proteins and related methods
    Publication number: 20060286630
    Abstract: The application provides novel complexes of POSH polypeptides and POSH-associated proteins. The application also provides methods and compositions for treating POSH-associated diseases such as viral disorders, cancer, and neurological disorders.
    Type: Application
    Filed: March 2, 2004
    Publication date: December 21, 2006
    Applicant: Proteologics, Inc.
    Inventors: Daniel Taglicht, Iris Alroy, Yuval Reiss, Liora Yaar, Danny Ben-Avraham, Shmuel Tuvia, Tsvika Greener
  • Trans-golgi network-associated processes, methods and compositions related thereto
    Publication number: 20060287337
    Abstract: The application discloses methods and compositions related to the modulation of trans-Golgi network-associated processes, including methods and compositions for the modulation of trans-Golgi network-associated proteins and methods for the treatment of disorders associated with trans-Golgi network processes.
    Type: Application
    Filed: May 11, 2005
    Publication date: December 21, 2006
    Applicant: Proteologics, Inc.
    Inventors: Yuval Reiss, Iris Alroy, Shmuel Tuvia, Liora Yaar, Daniel Taglicht